Abstract
Background
Rare diseases are a new global health priority, requiring evidence-based estimates of the global prevalence of diseases to inform public policymakers and provide a serious challenge to the healthcare system that must not be ignored. The purpose of this study is to investigate Iranian future healthcare professionals' knowledge and opinions about rare diseases.
Results
A total of 6838 students responded to the questionnaire. Nursing and medical students had the highest participation. Almost 85% of participants rated their knowledge about rare diseases as poor or insufficient. While nearly 70 percent of participants took courses about rare diseases at university. Finally, 72.7% of future healthcare professionals did not feel ready to take care of a patient with a rare disease.
Conclusion
The present study has indicated a gap in Iranian medical students’ knowledge of rare diseases. The researchers believe that health science policymakers should make a joint effort to improve knowledge about rare diseases. Including courses with regard to rare diseases would be of benefit to future healthcare professionals.
Keywords: Rare diseases, Education, Awareness, Healthcare professionals
Introduction
Rare diseases (RDs) are a new global health priority, requiring evidence-based estimates of the global prevalence of diseases to inform public policymakers. When a disease affects less than one in 2000 persons, it is considered as rare [1]. According to available information, 309 RDs have been diagnosed in Iran so far. Currently, around 3 million people with RDs have been identified in Iran and are receiving a variety of support services. Patients cared for by the Rare Diseases Foundation can benefit from a 50% discount on medicines by going to the Red Crescent. The Red Crescent is a non-governmental organization dedicated to humanitarian activities. In addition, it is a government-funded charity that also works to reduce the cost of treating patients with RDs. One of the most important missions of the Rare Diseases Foundation is to improve the lives of people with these diseases by raising awareness in the family and the community [2].
Rare diseases provide a serious challenge to the healthcare system that must not be ignored. Patients with RDs typically experience a lack of treatment alternatives, psychological stress, the financial burden in addition to the burden of disease [3]. Furthermore, these patients face challenges in obtaining a diagnosis of their illness, as it frequently takes 5–6 years to obtain an accurate diagnosis, and more than three different physicians are involved in the diagnosis process [4, 5]. Besides, due to a lack of knowledge about rare diseases and the challenges in properly diagnosing them, many patients with RDs would have visited multiple clinics or hospitals but only received symptomatic therapy [6].
One of the most common variables leading to the diagnostic odyssey is a lack of RD awareness and expertise among healthcare professionals [7]. Previous research has found that RD knowledge is typically considered inadequate by physicians and other health care professionals [8–10]. The majority of them believed their academic expertise was insufficient and unsuitable for diagnosing RDs in everyday practice [7, 11]. While physicians are responsible for managing the care processes of patients with RDs, the role of other health care professionals, including nurses and physiotherapists, is increasing. As a result, the need to increase knowledge and awareness of RD is evident among health care professionals [9]. Unfortunately, no study with a similar purpose was found in Iran and the knowledge of health care students is unknown. Due to the lack of basic information about the medical education curriculum in the field of rare diseases, we cannot predict the strength of the executive curriculum in the country's medical sciences universities.
Due to the importance of the subject, the purpose of this study is to investigate Iranian future healthcare professionals' knowledge and opinions about rare diseases.
Methods
A cross-sectional survey-based study was conducted in Iran from September 2021 to January 2022 using convenience sampling. Our target population consisted of students of health care professionals who had completed two years of education and had access to the Internet. Data collection was carried out via online feedback from participants during the survey. An online questionnaire (Google Form) was administered which also contains the motivation letter explaining the purpose of the participant’s response, and the hyperlink to the questionnaire was eventually published by the authors in the virtual student groups of the medical universities of the whole country that had access. To control the answers, each researcher was given a three-digit number and a section was added to the online questionnaire to allow participants who received the questionnaire link from a trusted researcher could enter the researcher's three-digit code. This was done to ensure that the answers were genuine. Incorrect code answers were excluded from the study. The online questionnaire was designed in order that individuals can withdraw at any time. Over 10,000 students from all medical sciences universities participated in this study, and after removing those who did not meet the inclusion criteria or fill out the questionnaire incompletely, we reached 6838 eligible participants.
Measures
Demographic checklist
Includes: age, gender, marital status, the field of study, grade, duration of education, and domicile.
Knowledge and attitudes of rare diseases questionnaire
The questionnaire used in the present study was developed by Domaradzki et al. based on the previous literature review and the aim of the study. The detailed description of the questionnaire and the method of its construction are explained elsewhere [9, 10].
In summary, the questionnaire consisted of 26 questions: the first questions concerned students' basic knowledge of RDs. Students were also asked to name RDs from a list that included twenty-eight diseases: 10 most common conditions and 18 RDs. The second section covered questions on organizational issues. The third section consisted of questions on students' awareness of RDs and their self-assessment knowledge and skills in the field of RDs.
The methodological procedures for the translation and cultural adaptation of the current questionnaire were employed as suggested by Beaton et al. according to a formal forward/backward translation protocol [12]. In the next step, some questions changed based on the cultural policies of Iran (questions: 6, 7, 12–18). The prepared version of the questionnaire was sent to 15 experts (Experts including nurse, physician, geneticist, sociologist, and physiotherapist) who were invited to give their opinion in order to improve the final version.
Content validity includes Content Validity Ratio (CVR) and Content Validity Index (CVI). Fifteen experts reviewed the questionnaire items and chose one of the essential, useful but not necessary, or unnecessary options [13]. According to the Lawshe table, the acceptance rate is 0.49 [14]. None of the phrases have been deleted in this section. After applying expert opinions and enriching the phrases, 15 other experts reviewed the questionnaire to evaluate CVI [15].
Data analysis
Data were entered into SPSS software version 18 and reported in frequency, percentage, mean, and standard deviation. Differences in proportion were tested with the Chi-square test if any cells had an expected count smaller than 5. A statistical analysis of possible answers’ differences between all study groups was performed using the Kruskal–Wallis test. The level of significance was set at p < 0.05.
Ethics
The study procedures were approved by the Clinical Research Development Unit (CRDU) of Sayad Shirazi Hospital of Golestan University of Medical Sciences and Ethical Review Board (IR.GOUMS.REC.1400.194). All participants entered the study with knowledge of the purpose of the study and informed consent and were informed that they could withdraw from the study at any time.
Results
A total of 6838 people responded to the questionnaire. The majority of the participants were women (60.1%). Nursing and medical students also had the highest participation, 34.2% and 40% respectively. The demographics of the participants can be seen in Table 1. In the process of evaluating the content validity, no items were removed from the research, but changes were made in the form and richness of the words for better understanding. The CVR value was 0.5–0.9 for the items and 0.73 for the whole scale.
Table 1.
Socio-demographic characteristics of students
| Characteristics | N (%) |
|---|---|
| Gender | |
| Male | 2731 (39.9) |
| Female | 4107 (60.1) |
| Field of study | |
| Medical students | 2732 (40) |
| Nursing students | 2338 (34.2) |
| Midwifery students | 637 (9.3) |
| Dentistry students | 425 (6.2) |
| Physiotherapy students | 111 (1.6) |
| Pharmacy students | 490 (7.2) |
| Occupational and speech therapist students | 105 (1.5) |
| Grade | |
| Bachelor degree | 2807 (53.7) |
| Master degree | 357 (5.2) |
| MD and DDS | 3674 (53.7) |
| Marital status | |
| Single | 6003 (87.8) |
| Married | 835 (12.2) |
| Age (year) | 22.7 ± 3.6 |
| Duration of education (year) | 5.6 ± 2.3 |
| Domicile | |
| Under 10,000 inhabitants | 423 (6.2) |
| 10–50,000 inhabitants | 1219 (17.8) |
| 51–100,000 inhabitants | 921 (13.5) |
| 101–500,000 inhabitants | 1271 (18.6) |
| Over 500,000 inhabitants | 3..4 (43.9) |
| Have you ever met a person suffering from RD? | |
| Yes | 3105 (45.4) |
| No | 2154 (31.5) |
| I do not know | 1579 (23.1) |
Values are presented as n (%), mean ± standard deviation
Although almost all of the participants had heard of the term “rare disease” (96.4%), they were not sufficiently aware of its prevalence in the community (3.9%). only 8.5% correctly estimated the number of RD (Table 2). Students' knowledge about the number of RD patients in the world (6.2%), Asia (3.8%), and Iran (3.8%) was low. A quarter of future healthcare professionals knew the percentage of RDs that were genetic (24.8%). Most participants used the “I do not know” option when responding to the questions.
Table 2.
Students' knowledge about rare diseases
| Items | Medicals | Nursings | Others | P-value |
|---|---|---|---|---|
| N (%) | ||||
| 1. Have you ever heard the term 'rare diseases'? | ||||
| Yes | 2636 (96.5) | 2252 (96.3) | 1701 (96.2) | 0.884 |
| No | 96 (3.5) | 86 (3.7) | 67 (3.8) | |
| 2. Rare disease is the one that affects less than: | ||||
| 1 person in 1000 | 320 (11.7) | 276 (11.8) | 224 (12.7) | 0.979 |
| 1 person in 2000 | 107 (3.9) | 89 (3.8) | 68 (3.8) | |
| 1 person in 3000 | 91 (3.3) | 73 (3.1) | 55 (3.1) | |
| 1 person in 5000 | 135 (4.9) | 116 (5) | 76 (4.3) | |
| 1 person in 10,000 | 853 (31.2) | 770 (32.9) | 577 (32.6) | |
| I do not know | 1226 (44.9) | 1014 (43.4) | 768 (43.4) | |
| 3. What is the estimated number of rare diseases? | ||||
| 100–500 | 196 (7.2) | 187 (8) | 129 (7.3) | 0.082 |
| 1000–2000 | 282 (10.3) | 237 (10.1) | 160 (9) | |
| 3000–5000 | 209 (7.7) | 128 (5.5) | 100 (5.7) | |
| 6000–8000 | 211 (7.7) | 203 (8.7) | 170 (9.6) | |
| 9000–1000 | 65 (2.4) | 78 (3.3) | 53 (3) | |
| Over 10,000 | 168 (6.1) | 140 (6) | 80 (4.5) | |
| I do not know | 1601 (58.6) | 1365 (58.4) | 1076 (60.9) | |
| 4. At what age group do rare diseases most frequently appear? | ||||
| Newborns | 680 (24.9) | 640 (27.4) | 467 (26.4) | 0.095 |
| Children | 663 (24.3) | 581 (24.9) | 390 (22.1) | |
| Adolescents | 83 (3) | 59 (2.5) | 58 (3.3) | |
| Adults | 135 (4.9) | 101 (4.3) | 76 (4.3) | |
| They are present in all age groups equally | 404 (14.8) | 324 (13.9) | 273 (15.4) | |
| I do not know | 767 (28.1) | 633 (27.1) | 504 (28.5) | |
| 5. How many people suffer from rare diseases worldwide? | ||||
| 10–15,000,000 | 142 (5.2) | 145 (6.2) | 103 (5.8) | 0.592 |
| 50–75,000,000 | 213 (7.8) | 143 (6.1) | 121 (6.8) | |
| 100–150,000,000 | 193 (7.1) | 181 (7.7) | 122 (6.9) | |
| 200–250,000,000 | 126 (4.6) | 128 (5.5) | 90 (5.1) | |
| 300–350,000,000 | 172 (6.3) | 149 (6.4) | 100 (5.7) | |
| Over 500,000,000 | 74 (2.7) | 60 (2.6) | 44 (2.5) | |
| I do not know | 1812 (66.3) | 1532 (65.5) | 1188 (67.2) | |
| 6. How many people in the Asia suffer from rare diseases? | ||||
| 10–50,000,000 | 259 (9.5) | 260 (11.1) | 167 (9.4) | 0.336 |
| 50–100,000,000 | 197 (7.2) | 171 (7.3) | 113 (6.4) | |
| 100–200,000,000 | 138 (5.1) | 106 (4.5) | 84 (4.8) | |
| 200–250,000,000 | 74 (2.7) | 49 (2.1) | 40 (2.3) | |
| 250–300,000,000 | 112 (4.1) | 95 (4.1) | 57 (3.3) | |
| I do not know | 1952 (71.4) | 1657 (70.9) | 1307 (73.9) | |
| 7. How many people suffer from rare diseases in Iran? | ||||
| 10–50,000 | 258 (9.4) | 250 (10.7) | 167 (9.4) | 0.507 |
| 100–300,000 | 253 (9.3) | 219 (9.4) | 153 (8.7) | |
| 300–500,000 | 201 (7.4) | 154 (6.6) | 114 (6.4) | |
| 1–1,500,000 | 213 (7.8) | 194 (8.3) | 128 (7.2) | |
| Over 2,000,000 | 96 (3.5) | 95 (4.1) | 72 (4.1) | |
| I do not know | 1711 (62.6) | 1426 (61) | 1134 (64.1) | |
| 8. What is the most common cause of rare diseases? | ||||
| Infectious and bacterial | 91 (3.3) | 49 (2.1) | 49 (2.8) | 0.421 |
| Genetic | 1911 (69.9) | 1674 (71.6) | 1244 (70.4) | |
| Autoimmune | 233 (8.5) | 245 (10.5) | 176 (10) | |
| Mitochondrial | 39 (1.4) | 27 (1.2) | 23 (1.3) | |
| Environmental | 50 (1.8) | 42 (1.8) | 30 (1.7) | |
| I do not know | 408 (14.9) | 301 (12.9) | 246 (13.9) | |
| 9. What percentage of rare diseases are of genetic origin? | ||||
| 5–10% | 270 (9.9) | 227 (9.7) | 180 (10.2) | 0.911 |
| 20% | 285 (10.4) | 235 (10.1) | 177 (10) | |
| 50% | 363 (13.3) | 323 (13.8) | 220 (12.4) | |
| 80% | 676 (24.7) | 585 (25) | 432 (24.4) | |
| 100% | 0 (0) | 0 (0) | 0 (0) | |
| I do not know | 1138 (41.7) | 968 (41.4) | 759 (42.9) | |
The correct answers to the questions are presented in bold
Participants selected rare diseases from a list of 28 diseases (Table 3). The most recognized RD were: Sickle cell anemia (30.2%), Marfan syndrome (28.6%), and Gaucher disease (28%). Least often were indicated Pompe disease (10.5%) and Osteogenesis imperfecta (9.9%). In contrast, the diseases most frequently confused with RD were Crohn’s disease (31.6%), Cerebral palsy (25.7%), and Glaucoma (21%).
Table 3.
Which of the following diseases are considered to be rare in Iran?
| Items | N (%) | P-value |
|---|---|---|
| Fragile X syndrome | 1365 (20) | |
| Alzheimer’s disease | 1499 (21.9) | |
| Progeria | 1006 (14.7) | |
| Duchenne muscular dystrophy | 1466 (21.4) | |
| Crohn’s disease | 2164 (31.6) | |
| Niemann-Pick disease | 1029 (15) | |
| Huntington disease | 1342 (19.6) | |
| Cerebral palsy | 1758 (25.7) | |
| Marfan syndrome | 1957 (28.6) | |
| Phenylketonuria | 1165 (17) | |
| Munchausen syndrome | 438 (6.4) | |
| Sickle cell anemia | 2064 (30.2) | |
| Down syndrome | 1070 (15.6) | 0.012 |
| Acromegaly | 1077 (15.8) | |
| Osteogenesis imperfect | 680 (9.9) | |
| Pompe disease | 715 (10.5) | |
| Schizophrenia | 322 (4.7) | |
| Mucopolysaccharidosis | 1782 (26.1) | |
| Gaucher disease | 1916 (28) | |
| Halitosis | 857 (12.5) | |
| Haemophilia | 1618 (23.7) | |
| Craniodiaphyseal dysplasia | 1312 (19.2) | |
| Glaucoma | 1438 (21) | 0.01 |
| Neurofibromatosis | 1037 (15.2) | |
| Achondroplasia | 874 (12.8) | |
| Cystic fibrosis | 1482 (21.7) | |
| Acquired immunodeficiency syndrome | 1317 (19.3) | 0.018 |
| Fibromyalgia | 532 (7.8) |
The correct answers to the questions are presented in bold
Future healthcare professionals' practical information about RD is shown in Table 3. Only 9.8% of participants were aware of the Iranian website (Rare Diseases Foundation of Iran) that provided information about RDs (https://radoir.org/). This is while about 59% of the participants were aware of the central register of RD patients in Iran and about 43% of them were aware of the existence of a national plan for RDs in Iran. Nursing students, compared to other students, mistakenly selected three diseases (Down syndrome, glaucoma, and Acquired immunodeficiency syndrome) as rare diseases (P < 0.05).
Students' perceptions of their knowledge of rare diseases are shown in Table 4. Almost 85% of participants rated their knowledge about rare diseases as poor or insufficient. While nearly 70 percent of participants took courses about rare diseases at university, a small number of them declared their knowledge because of the university courses. 60.3% of participants indicated that rare diseases are serious public health issues and, in their opinion, family physicians (49.3%) and geneticists (64.6%) should be trained specifically in rare diseases. Finally, 72.7% of future healthcare professionals did not feel ready to take care of a patient with a rare disease.
Table 4.
Students' knowledge about healthcare system for RD patients
| Items | Medicals | Nursings | Others | P value |
|---|---|---|---|---|
| N (%) | ||||
| 11. What percentage of rare disease can be treated with drugs? | ||||
| 0% | 212 (7.8) | 168 (7.1) | 121 (6.8) | 0.84 |
| 5% | 326 (11.9) | 278 (11.9) | 220 (12.4) | |
| 10% | 235 (8.6) | 234 (10) | 161 (9.1) | |
| 15% | 168 (6.1) | 151 (6.5) | 109 (6.2) | |
| 20% | 183 (6.7) | 171 (7.3) | 123 (7) | |
| 50% | 85 (3.1) | 54 (2.3) | 57 (3.2) | |
| I do not know | 1523 (55.7) | 1283 (54.9) | 977 (55.3) | |
| 12. When is rare disease day celebrated? | ||||
| January 26 | 79 (2.9) | 59 (2.5) | 51 (2.9) | 0.77 |
| February 26 | 489 (17.9) | 414 (17.7) | 328 (18.6) | |
| March 26 | 67 (2.5) | 68 (2.9) | 50 (2.8) | |
| April 26 | 94 (3.4) | 90 (3.8) | 58 (3.3) | |
| I do not know | 2003 (73.3) | 1707 (73) | 1281 (72.5) | |
| 13. The Iranian non-governmental patient’s organization in the field of rare diseases is: | ||||
| Ghoghnoos | 132 (4.8) | 113 (4.8) | 79 (4.5) | 0.25 |
| Iranian Rare Diseases Foundation | 575 (21) | 529 (22.6) | 366 (20.7) | |
| Zanjireh Omid International Charity | 185 (6.8) | 187 (8) | 109 (6.2) | |
| Rare Disease Protection O | 292 (10.7) | 242 (10.4) | 202 (11.4) | |
| I do not know | 1548 (56.7) | 1267 (54.2) | 1012 (57.2) | |
| 14. What is the name of the Iranian website providing information about RD and orphan drugs? | ||||
| Radoir | 255 (9.3) | 229 (9.8) | 185 (10.5) | 0.46 |
| NORD | 173 (6.3) | 137 (5.9) | 103 (5.8) | |
| EURORDIS | 59 (2.2) | 38 (1.6) | 39 (2.2) | |
| RARE | 167 (6.1) | 167 (7.1) | 99 (5.6) | |
| Orphanet | 65 (2.4) | 45 (1.9) | 33 (1.3) | |
| Global Genes | 28 (1) | 32 (1.4) | 23 (1.3) | |
| I do not know | 1985 (72.7) | 1690 (72.3) | 1286 (72.7) | |
| 15. Is Iran a member of the world organization for rare diseases? | ||||
| Yes | 1088 (39.8) | 923 (39.5) | 672 (38) | 0.45 |
| No | 186 (6.8) | 187 (8) | 137 (7.7) | |
| I do not Know | 1458 (53.4) | 1228 (52.5) | 959 (54.2) | |
| 16. Is there a central register of RD patients in Iran? | ||||
| Yes | 1499 (54.9) | 1253 (53.6) | 999 (56.5) | 0.17 |
| No | 154 (5.6) | 161 (6.6) | 88 (5) | |
| I do not know | 1079 (39.5) | 924 (39.5) | 681 (38.5) | |
| 17. Are orphan drugs reimbursed in Iran? | ||||
| Yes | 800 (29.3) | 608 (26) | 517 (29.2) | 0.007 |
| Yes, some | 1139 (41.7) | 977 (41.8) | 718 (40.6) | |
| No | 0 (0) | 0 (0) | 0 (0) | |
| I do not know | 793 (29) | 753 (32.2) | 533 (30.1) | |
| 18. Is there a national plan for rare diseases in Iran? | ||||
| Yes | 795 (29.1) | 681 (29.1) | 561 (31.7) | 0.117 |
| No | 490 (17.9) | 463 (19.8) | 284 (16.1) | |
| I do not know | 1447 (53) | 1194 (51.1) | 923 (52.2) | |
The correct answers to the questions are presented in bold
None of the demographic items had a significant relationship with students' knowledge and attitudes (P > 0.05). Students' self-assessment of their knowledge about RD is shown in Table 5.
Table 5.
Students' self-assessment of their knowledge about RD
| Items | Medical s | Nursing s | Other s | P value |
|---|---|---|---|---|
| N (%) | ||||
| Do RD constitute a serious public health issues? | ||||
| Absolutely yes | 820 (30.01) | 668 (28.57) | 516 (29.18) | 0.15 |
| Yes | 850 (31.11) | 700 (29.9) | 570 (32.23) | |
| No | 281 (10.2) | 239 (10.2) | 198 (11.19) | |
| Definitely no | 66 (2.41) | 51 (2.18) | 47 (2.65) | |
| I do not now | 715 (26.17) | 680 (29.08) | 437 (24.71) | |
| Which physicians should be uniquely trained in RD? | ||||
| Family physician | 1356 (49.6) | 1133 (48.5) | 881 (49.8) | – |
| Pediatrician | 932 (34.1) | 842 (36) | 602 (34) | |
| Neurologist | 497 (18.2) | 411 (17.6) | 329 (18.6) | |
| Geneticist | 1755 (64.2) | 1547 (66.2) | 1116 (63.1) | |
| Psychiatrist | 453 (16.6) | 402 (17.2) | 310 (17.5) | |
| Immunologist | 739 (27) | 629 (26.9) | 508 (28.7) | |
| Have you had any classes about rare disease during your studies? | ||||
| Yes | 1879 (68.8) | 1629 (69.7) | 1238 (70) | 0.63 |
| No | 594 (21.7) | 491 (21) | 383 (21.7) | |
| I do not know | 259 (9.5) | 218 (9.3) | 147 (8.3) | |
| How would you rate your knowledge about rare diseases? | ||||
| Very good | 51 (1.9) | 45 (1.9) | 29 (1.6) | 0.91 |
| Fair enough | 366 (13.4) | 279 (11.9) | 223 (12.6) | |
| Insufficient | 1197 (43.8) | 1072 (45.9) | 791 (44.7) | |
| Very poor | 1118 (40.9) | 942 (40.3) | 725 (71) | |
| Would you like to broaden your knowledge about rare diseases? | ||||
| Yes | 2213 (81) | 1865 (79.8) | 1403 (79.4) | 0.44 |
| No | 300 (11) | 292 (12.5) | 231 (13.1) | |
| I do not know | 219 (8) | 181 (7.7) | 134 (7.6) | |
| Do you think that there should be a mandatory course on rare diseases in medical curricula? | ||||
| Definitely yes | 584 (21.4) | 528 (22.6) | 382 (21.6) | 0.60 |
| Rather yes | 1378 (50.4) | 1168 (50) | 898 (50.8) | |
| Rather not | 423 (15.5) | 353 (15.1) | 258 (14.6) | |
| Definitely not | 188 (6.9) | 166 (7.1) | 135 (7.6) | |
| I do not know | 159 (5.8) | 123 (5.3) | 95 (5.4) | |
| Where do you get your knowledge about RD from? | ||||
| Mandatory courses at the university | 663 (24.3) | 590 (25.2) | 462 (26.1) | – |
| Faculty courses at the university | 193 (7.1) | 135 (5.8) | 142 (8) | |
| Scientific literature and research | 654 (23.9) | 533 (22.8) | 448 (25.3) | |
| Scientific conferences, symposia | 313 (11.5) | 231 (9.9) | 180 (10.2) | |
| Internet | 1517 (55.5) | 1332 (57) | 954 (54) | |
| I do not search for such information | 546 (20) | 442 (18.9) | 344 (19.5) | |
| Do you feel prepared for caring over a patient with a rare disease? | ||||
| Definitely yes | 164 (6) | 123 (5.3) | 91 (5.1) | 0.24 |
| Rather yes | 605 (22.1) | 508 (21.7) | 382 (21.6) | |
| Rather not | 858 (31.4) | 710 (30.4) | 544 (30.8) | |
| Definitely not | 814 (29.8) | 751 (32.1) | 552 (31.2) | |
| I do not know | 291 (10.7) | 246 (10.5) | 199 (11.3) | |
Discussion
According to the literature review, no studies were found in Iran examining the knowledge of future healthcare professionals about RD. Due to the growing understanding of the medical community about genetically based diseases, there is a need for educational programs in the area of RD in particular. As a result, future healthcare professionals often do not receive the necessary training in RD [16].
Consistent with previous studies [16–19], the results of the present study showed that future healthcare professionals receive little education about RD. Although almost all of the participating students were familiar with RD and most believed that RD was due to genetic factors, they had little knowledge of the epidemiology of RD. Many students have used the "I do not know" option and the problem of insufficient education is evident during their studies. In Iranian medical universities, basic sciences including biochemistry, physiology as well as genetics are taught in the first year. Regarding the major, it may continue or not. Numerous RDs such as PKU, CF, Huntington’s disease, and sickle cell disease are included in genetics courses. In addition to the diseases, diagnostic tests and major clinical manifestations are also taught. We hypothesize that medical sciences students (MSSs) learn the knowledge of RDs randomly and casually. The premise is according to the following reasons: 1) while most students were aware of their knowledge deficits, they had an unsatisfactory level of information on RDs. 2) RDs are not taught as a separate subject and in a systematic comprehensive form. Rather, it is considered a subset of genetics. So all of MSSs are deprived of training in relation to RDs. In line with our findings, previous studies [9, 20] authenticate the fact that the retention of MSSs’ knowledge and skills is compromised. Many studies, like our results, addressed the unfavorable level of knowledge of the students [10, 16, 17]. Using similar tools, Domaradzki et al. [9] pointed out that the students' knowledge was insufficient. The vast majority of respondents were also aware of their lack of knowledge. In their study, medical students were significantly better informed about RD than other students. However, the findings of our study showed that there was no significant difference in the knowledge and attitude of nursing, medical, and the other students. The results of a study conducted in Kazakhstan show that medical students and physicians suffer from inadequate education in rare diseases. They suggested an immediate revision of medical education standards [21].
In the present study, some of MSSs have selected the following diseases as RDs mistakenly: Crohn’s disease (31.6%), Cerebral palsy (25.7%), and Glaucoma (21%). The above-mentioned diseases are diseases which are well discussed in the classes. Lack of recognition of rare diseases from other diseases indicates that misdiagnosis can delay treatment. More interestingly, in high school education, some basic information about genetic disorders and RDs is already present, therefore this problem is rooted in an educational system which is consistent with Williams’ findings [22]. These results indicate that the medical sciences curriculum is likely to be disrupted and inappropriate.
Moreover, there is no specific course, guideline, or recommendations at Iranian universities pertaining to RDs. Our medical education system usually focuses on more prevalent disorders and prepares students for facing conventional diseases rather than rare ones. More studies in this field are needed to determine whether an elective or mandatory course on RDs should be included in the medical education curriculum.
Additionally, preparing a comprehensive content including multidimensional information about RDs like prevalence, incidence, the relevance of RDs to everyday medical care, early detection, potential treatment strategies, and the last but not least, the challenges that healthcare workers face during admission of RD patients is necessary. Healthcare workers have to know sources of information and support for RD patients to help RD patients’ families and caregivers.
McKay [23] suggests that teaching programs should not focus on any particular RD. There are an estimated 6000–8000 different types of RDs and focusing on all RDs is impossible. Trying to raise public awareness about cursory knowledge of the prevalence and incidence of RDs would be of profound importance. Pisklakov acknowledges that health professionals’ false beliefs may interfere with their attitude and disrupt the situation. This is of key importance because health professionals’ false beliefs in their knowledge and skills make it difficult to change the situation of patients with rare diseases [24] Alawi et al. [25] suggest using RDs as a teaching model to transfer the basic sciences and clinical practice to students.
The findings of our study showed that there was no significant difference in the knowledge and attitude of nursing, medical, and the other students.
The present study has limitations, the most important of which is the content validity of the questionnaire. The items used in the questionnaire used were made in accordance with the conditions of Poland and European policies. Therefore, it cannot adequately cover all the required aspects of Iran's health policy. It is proposed to conduct more detailed studies to create a questionnaire according to Iran's health policy. The questionnaire may not effectively measure numerous concepts such as diagnosis, care, and treatment. It is suggested that future studies explore other concepts in the curricula of universities of medical science.
In conclusion, the present study shows that, according to the participants' answers, the existence of curricula on rare diseases is not enough for them and they do not feel ready to care for patients with rare diseases. We have shown that a fundamental problem exists and we suggest that future researchers look into the causes of this problem so that steps can be taken to improve the current situation.
Conclusion
The present study has indicated a gap in Iranian medical students’ knowledge of RDs. The researchers believe that health science policymakers should make a joint effort to improve knowledge about RDs. Including courses with regard to RDs would be of benefit to future healthcare professionals, the importance of pharmaceutical education on orphan drugs which could be included in the medical curricula; the need to establish closer collaboration with other neighboring countries, the role of machine learning and artificial intelligence that can support the decision process and overcome barriers that affect the diagnostic odyssey and the role of telemedicine and telepharmacy services in providing RD patients the opportunity to continue treatment.
Acknowledgements
All students who somehow participated in this study are sincerely appreciated. Finally, thanks to the Student Research Committee of Golestan University of Medical Sciences.
Author contributions
RJ was responsible for analyzing the data, drafting the manuscript, reviewing the manuscript, and approving the final version. AN was responsible for collecting data, analyzing the data, drafting the manuscript, and approving the final version. MF was responsible for collecting data and approving the final version. SB, MF, KA, AF, SB, MS, AA, KE, NN, FS, HM, EY, SB, NM, EM, SA, and FT were responsible for collecting data. JD and AS were responsible for reviewing the manuscript and approving the final version. LJ was responsible for designing the study, reviewing the manuscript, and approving the final version. All authors read and approved the final manuscript.
Funding
None.
Availability of data and materials
All data generated or analyzed during this study are included in this published article.
Declarations
Ethics approval and consent to participate
This study was conducted following receipt of the ethics approval (IR.GOUMS.REC.1400.194) from the Golestan University of Medical Sciences. All students gave informed consent for the use of data for research purposes.
Consent for publication
Not applicable.
Competing interests
The authors declare that there is no conflict of interest.
Footnotes
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Contributor Information
Reza Jahanshahi, Email: rjahanshahi75@yahoo.com.
Amirreza Nasirzadeh, Email: nasirzadeharnz@gmail.com.
Mahan Farzan, Email: st-farzan.mahan@skums.ac.ir.
Jan Domaradzki, Email: jandomar@ump.edu.pl.
Leila Jouybari, Email: jouybari@goums.ac.ir.
Akram Sanagoo, Email: sanagoo@goums.ac.ir.
Mahour Farzan, Email: st-farzan.mahour@skums.ac.ir.
Komeil Aghazadeh-Habashi, Email: komeil.aghazade@gmail.com.
Ahmadreza Fallah Faraghe, Email: ahmadreza.fallahfaraghe1928@gmail.com.
Sadegh Bagheri, Email: s.bagheri5161@gmail.com.
Marziyeh Samiee, Email: Marziyehsamiei@gmail.com.
Arina Ansari, Email: arinaansari80@gmail.com.
Kimia Eskandari, Email: kimia.eskandari2000@gmail.com.
Negar Namakkoobi, Email: n.namakkoobi78@gmail.com.
Fatemeh Soltanimoghadam, Email: Soltani.f2790@gmail.com.
Hadi Mashali, Email: Hadimashali@sums.ac.ir.
Erfan Yavari, Email: rfnyavari@gmail.com.
Saba Bay, Email: Sababauy9@gmail.com.
Nafiseh Memaripanah, Email: mphnafise@gmail.com.
Elahe Meftah, Email: e-Meftah@student.tums.ac.ir.
Saeed Amanzadeh, Email: sa3edmd@gmail.com.
Fatemeh Talati, Email: fateme_talati@yahoo.com.
Sasan Bahramzadeh, Email: Chainedto2017@gmail.com.
References
- 1.Radoir. Rare diseases foundation of Iran. Estimating the prevalence of rare diseases: analysis of Orphan data. 2020. https://b2n.ir/b30736. Accessed 26 Mar 2022.
- 2.Saki C, Hamzehzadeh A. Atlas of the rare diseases in Iran. Iran: Urmia University of Medical Sciences; 2019. https://radoir.org/fa//wp-content/uploads/2017/08/atlas.pdf.
- 3.Schadewald A, Kimball E, Ou L. Coping strategies, stress, and support needs in caregivers of children with mucopolysaccharidosis. JIMD Rep. 2018;42:89–97. doi: 10.1007/8904_2017_87. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Zurynski Y, Deverell M, Dalkeith T, Johnson S, Christodoulou J, Leonard H, et al. Australian children living with rare diseases: experiences of diagnosis and perceived consequences of diagnostic delays. Orphanet J Rare Dis. 2017;12(1):1–9. doi: 10.1186/s13023-017-0622-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Pelentsov LJ, Fielder AL, Laws TA, Esterman AJ. The supportive care needs of parents with a child with a rare disease: results of an online survey. BMC Fam Pract. 2016;17(1):1–13. doi: 10.1186/s12875-016-0488-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Anderson M, Elliott EJ, Zurynski YA. Australian families living with rare disease: experiences of diagnosis, health services use and needs for psychosocial support. Orphanet J Rare Dis. 2013;8:1–9. doi: 10.1186/1750-1172-8-22. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Sanges S, Farhat MM, Assaraf M, Galland J, Rivière E, Roubille C, et al. Raising rare disease awareness using red flags, role play simulation and patient educators: results of a novel educational workshop on Raynaud phenomenon and systemic sclerosis. Orphanet J Rare Dis. 2020;15(1):159. doi: 10.1186/s13023-020-01439-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Vandeborne L, van Overbeeke E, Dooms M, De Beleyr B, Huys I. Information needs of physicians regarding the diagnosis of rare diseases: a questionnaire-based study in Belgium. Orphanet J Rare Dis. 2019;14:99. doi: 10.1186/s13023-019-1075-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Domaradzki J, Walkowiak D. Knowledge and attitudes of future healthcare professionals towards rare diseases. Front Genet. 2021;12:639610. doi: 10.3389/fgene.2021.639610. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Domaradzki J, Walkowiak D. Medical students' knowledge and opinions about rare diseases: a case study from Poland. Intractable Rare Dis Res. 2019;8(4):252–259. doi: 10.5582/irdr.2019.01099. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Ramalle-Gómara E, Domínguez-Garrido E, Gómez-Eguílaz M, Marzo-Sola ME, Ramón-Trapero JL, Gil-de-Gómez J. Education and information needs for physicians about rare diseases in Spain. Orphanet J Rare Dis. 2020;15(1):18. doi: 10.1186/s13023-019-1285-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Beaton DE, Bombardier C, Guillemin F, Ferraz MB. Guidelines for the process of cross-cultural adaptation of self-report measures. Spine. 2000;25(24):3186–3191. doi: 10.1097/00007632-200012150-00014. [DOI] [PubMed] [Google Scholar]
- 13.Hajizadeh E, Asghari M. Methods and statistical analyzes by looking at the research method in the life sciences and health sciences, Tehran: Publishing Co., Jihad University; 2015. [Google Scholar]
- 14.Lawshe CH. A quantitative approach to content validity. Pers Psychol. 1975;28(4):563–575. doi: 10.1111/j.1744-6570.1975.tb01393.x. [DOI] [Google Scholar]
- 15.Polit DF, Beck CT. The content validity index: are you sure you know what's being reported? Critique and recommendations. Res Nurs Health. 2006;29(5):489–497. doi: 10.1002/nur.20147. [DOI] [PubMed] [Google Scholar]
- 16.Jonas K, Waligóra M, Hołda M, Sulicka-Grodzicka J, Strach M, Podolec P, et al. Knowledge of rare diseases among health care students–the effect of targeted education. Przegl Epidemiol. 2017;71(1):80–89. [PubMed] [Google Scholar]
- 17.Alam T, Hameed A, Naveed S, Sharif N. Rare diseases: awareness amongst pharmacy students in Karachi, Pakistan. RADS-JPPS. 2016;4(1):96–101. [Google Scholar]
- 18.Kopeć G, Podolec P. Establishing a curriculum on rare diseases for medical students. J Rare Cardiovasc Dis. 2015;2(3):74–6. doi: 10.20418/jrcd.vol2no3.194. [DOI] [Google Scholar]
- 19.Ramalle-Gómara E, Ruiz E, Quiñones C, Andrés S, Iruzubieta J, Gil-de-Gómez J. General knowledge and opinion of future health care and non-health care professionals on rare diseases. J Eval Clin Pract. 2015;21(2):198–201. doi: 10.1111/jep.12281. [DOI] [PubMed] [Google Scholar]
- 20.Greb AE, Brennan S, McParlane L, Page R, Bridge PD. Retention of medical genetics knowledge and skills by medical students. Genet Med. 2009;11:365–370. doi: 10.1097/GIM.0b013e31819c6b2d. [DOI] [PubMed] [Google Scholar]
- 21.Walkowiak D, Bokayeva K, Miraleyeva A, Domaradzki J. The awareness of rare diseases among medical students and practicing physicians in the Republic of Kazakhstan. An exploratory study. Public Health Front. 2022;10:861. doi: 10.3389/fpubh.2022.872648. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Williams LZJ. Repurposing a rare opportunity: a brief insight into how implicit bias towards biomedicine impacts the care received by patients with a rare illness. Orphanet J Rare Dis. 2019;14:1–3. doi: 10.1186/s13023-019-1024-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.McKay L. From amyloidosis to Zellweger syndrome: how can the medical education system include thousands of rare diseases? NZMSJ. 2019;29:7–10. [Google Scholar]
- 24.Pisklakov S, Rimal J, McGuirt S. Role of self-evaluation and self-assessment in medical student and resident education. Br J Educ Soc Behav Sci. 2014;4:1–9. doi: 10.9734/BJESBS/2014/5066. [DOI] [Google Scholar]
- 25.Alawi F. Using rare diseases as teaching models to increase awareness. Oral Surg Oral Med Oral Pathol Oral Radiol. 2019;128(2):99–100. doi: 10.1016/j.oooo.2019.04.015. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
All data generated or analyzed during this study are included in this published article.